Director/PDMR Shareholding

Deltex Medical Group PLC
27 October 2005


                            Deltex Medical Group plc

                            Directors' Shareholdings


27 October 2005: Deltex Medical Group plc ('the Company'), the AIM listed
haemodynamic monitoring company, announces that the Chairman, Nigel Keen, has
notified the Company of a purchase of 263,158 ordinary shares at a price of
19.25 pence per share.

Following the above purchase, the directors' beneficial interests are as
follows:


Name of Director                    Number of shares      Holding of shares   % of enlarged issued
                                 purchased on market       following issue/          share capital
                                                                   purchase

Nigel Keen (1)                               263,158              4,126,884                  5.67%
Dr Edwin Snape (2)                                 -              3,164,074                  4.35%
Peter Smedvig (3)                                  -              1,098,439                  1.51%
Andy Hill                                          -                 42,857                  0.06%
Ewan Phillips                                      -                714,656                  0.99%
George Flouty                                      -                244,671                  0.34%
Sir Duncan Nichol                                  -                 36,947                  0.05%

Total                                        263,158              9,428,528                 12.97%


(1)  Includes 589,700 shares held as trustee and executor of Pauline Thomas
Charity Will Trust.

(2)  Includes shares held as a director of New England Partners and associated
companies.

(3)  Includes shares held as director of Peder Smedvig Capital AS.




For further information, please contact:-

Deltex Medical Group plc                                                01243 774 837
Nigel Keen, Chairman                                                    [e-mail]
Andy Hill, Chief Executive                                              [e-mail]
Ewan Phillips, Finance Director                                         [e-mail]

Charles Stanley                                                         0207 953 2000
Philip Davies

Financial Dynamics
David Yates/John Gilbert                                                0207 831 3113



                      This information is provided by RNS
            The company news service from the London Stock Exchange